I believe investors need to ask themselves what PS

I believe investors need to ask themselves what PSTI's market cap should be when it's benefits with pneumonia is proven. Now ask yourself if during the current coronavirus pandemic if that could be the case in a month or less, rather than years of clinical trials. I believe this is very possible given the initial trial in Israel.

I certainly don't know, but hope that efforts in Israel and Germany expand to hundreds of patients, and if they do, and if those hundreds of patients have outcomes resembling the first 7 to be announced, don't you think many countries will accept the drug without further testing. I believe it will, though it should have results reported in a verifying Phase 4. Our drug is potentially a game changer in terms of the threat of coronavirus.

If this comes to pass, wouldn't it make sense for PSTI's market cap to be in billions, perhaps even double digit billions. If we believe our O/S hasn't grown beyond 20 million shares, a billion dollar market cap equals a share price of $50, even if we're 25 million shares, it's $40.

Please don't get me wrong, eventually we should see billion dollar market caps on the strength of the clinical trials that are being run, but I'm suggesting it could happen in the next month if PLX-PAD truly proves effective for pneumonia, and realize it should work on all forms of pneumonia, not just that which is coronavirus based.

Gary